ReportBuyer.com, the online destination for business intelligence for major industry sectors, has added a new report describing the specific segment of the diagnostic market aimed at analysis cytology (the examination of cells using optical microscopy methods) specimens derived from the human female reproductive tract.

The publication Cytology and HPV Testing World Markets further examines the measurement devices and their reagents and supplies used in hospitals, clinics, commercial laboratories and research institutions to detect cells and proteins for the diagnosis and monitoring of cancer.

The report shows that cancer is a group of diseases characterised by uncontrolled growth and spread of abnormal cells – if it’s not controlled, it can result in death. Cancer is caused by both external (chemicals, radiation and viruses) and internal (hormones, immune conditions and inherited mutations) factors. Causal factors may act together or in sequence to initiate or promote carcinogenesis (the creation of cancer).

Authors of the report highlight that ten or more years often pass between exposures or mutations and detectable cancer. They further note that it is treated by surgery, radiation, chemotherapy, hormones and immunotherapy.

The study describes the analytical methods used to separate, isolate, characterise and quantitate cells, DNA and proteins complex in biological systems related to the diagnosis and treatment of disease of the female reproductive tract, such as the cervix and vagina. The emphasis is on those companies and products that are actively developing and marketing laboratory instrumentation, reagents and supplies for performing cytology and related molecular diagnostic tests, such as human papillomavirus (HPV) and other inflammatory and sexually-transmitted diseases.

ReportBuyer.com Product ID: TRI00035
ReportBuyer.com Category: Pharma and Healthcare